Therapy
Latest news and updates related to therapy
About Therapy coverage
The Therapy news hub on Global Investing News tracks breaking headlines that matter to investors, policy watchers, and market strategists. Use this page to monitor how Therapy developments affect earnings expectations, sector rotation, supply chains, regulation, and cross-asset volatility. Stories are grouped by source type — market data, company announcements, regulatory filings, and expert analysis — so you can scan the signal quickly without wading through duplicate wire copy. When a headline links to a full article, you will find expanded context, key facts, and prediction-market angles where available. Bookmark this hub if you follow Therapy across quarters; new items are added as our crawl pipeline ingests fresh sources throughout the trading day.
Explore related topics
Latest Therapy headlines
Market Data
(3)Sumitomo Pharma Shares Drop After Stem-Therapy Backing
Sumitomo Pharma Shares Drop After Stem-Therapy Backing
Eli Lilly to Buy Cell Therapy Company Orna for $2.4 Billion
Eli Lilly to Buy Cell Therapy Company Orna for $2.4 Billion
Eli Lilly Stock Rises. It’s Acquiring This Cell Therapy Company for $2.4 Billion.
Eli Lilly Stock Rises. It’s Acquiring This Cell Therapy Company for $2.4 Billion.
Other Sources
(4)Regeneron's Yancopoulos on Hearing Loss Gene Therapy, Weight Loss Drugs
George Yancopoulos, Regeneron's Chief Scientific Officer, discussed the company's advancements in gene therapy for hearing loss, highlighting the potential for groundbreaking treatments in a traditionally underserved area. He also touched upon their ongoing research and development in weight loss drugs, indicating Regeneron's strategic expansion into lucrative therapeutic markets beyond its established ophthalmology and oncology franchises.
Are you too old to see a therapist? As loneliness soars among seniors, the question is more relevant than ever.
This MarketWatch article addresses the increasing relevance of therapy for seniors, particularly as loneliness becomes a growing concern among this demographic. It challenges the societal perception that mental health support, like therapy, is only for younger individuals, highlighting the societal impact of untreated loneliness and mental health issues in older adults.
‘Women deserve an apology’: For menopause, hormone therapy is now considered safe — just in time for aging millennials
This MarketWatch article highlights a significant shift in the medical community's stance on hormone therapy for menopause, now being widely recognized as safe and effective for many women. This renewed understanding comes after decades of misinformation that deterred women from seeking crucial relief, coinciding with the eldest millennials approaching menopausal age, making this a timely and impactful development for a large demographic.
U.S. Physical Therapy (USPH) Stock Trades Up, Here Is Why
U.S. Physical Therapy (USPH) saw its stock price rise following its Q1 2024 earnings report, which indicated better-than-expected revenue and earnings per share. This positive performance suggests strong operational execution and potentially an optimistic outlook for the company's future growth in the healthcare sector.
Get alerts for this topic
Subscribe to receive updates about "Therapy"